Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

11 trials with published results (18%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

4 terminated out of 60 trials

Success Rate

89.2%

+2.6% vs benchmark

Late-Stage Pipeline

17%

10 trials in Phase 3/4

Results Transparency

33%

11 of 33 completed with results

Key Signals

11 with results89% success

Data Visualizations

Phase Distribution

48Total
Not Applicable (28)
P 1 (2)
P 2 (8)
P 3 (4)
P 4 (6)

Trial Status

Completed33
Recruiting7
Not Yet Recruiting7
Unknown5
Terminated4
Withdrawn2

Trial Success Rate

89.2%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (60)

Showing 20 of 20 trials
NCT04838769Not ApplicableActive Not RecruitingPrimary

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

NCT07430423Not Yet RecruitingPrimary

The FLOW Registry.

NCT07663344Not ApplicableNot Yet RecruitingPrimary

STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning

NCT07642063Not ApplicableEnrolling By Invitation

Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The Prostate

NCT07627178Not ApplicableRecruitingPrimary

A Prospective Comparative Study Evaluating the Safety and Efficacy of Transurethral Thulium Fiber Laser, Holmium Laser and Bipolar Enucleation of Large Sized Prostate

NCT04266418Not ApplicableCompletedPrimary

The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults

NCT07592299Not ApplicableNot Yet RecruitingPrimary

To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.

NCT04757116Not ApplicableRecruitingPrimary

Post-Market Study to Assess iTind Safety in Comparison to UroLift

NCT00651807Phase 2TerminatedPrimary

A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

NCT07242807Not Yet RecruitingPrimary

Minimally Invasive Prostate Interventions Registry (MIST Study)

NCT07016620RecruitingPrimary

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

NCT07277556Not Yet RecruitingPrimary

TURP Outcome Prediction Calculator Study

NCT06817733Not ApplicableRecruitingPrimary

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

NCT07016776Not Yet Recruiting

Uroflowmetry Curve Types and IPSS in Men With LUTS

NCT06769997Not ApplicableRecruitingPrimary

Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia

NCT05785286CompletedPrimary

To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire

NCT06772558Not ApplicableNot Yet Recruiting

Desflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperative Procedures by Modulating Cdc42 and Clock Proteins

NCT06062875Phase 2RecruitingPrimary

Effects of TNF Blockade on Human BPH/LUTS

NCT02026908Not ApplicableCompletedPrimary

Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)

NCT04681625Not ApplicableCompletedPrimary

Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder

Scroll to load more

Research Network

Activity Timeline